mTORc1 activity is necessary and sufficient for phosphorylation of eNOSS1177
Authors:
Open Access
- 21 June 2018
- journal article
- research article
- Published by Wiley in Physiological Reports
- Vol. 6 (12) , e13733
Abstract
Nitric oxide, produced by eNOS, plays critical roles in the regulation of vascular function and maintenance. Chronic PI3K signaling has recently been associated with vascular malformations. A well described substrate downstream of PI3K signaling is eNOS. Another critical downstream target of PI3K is the metabolic regulator, mTORc1. The relationship between mTORc1 and eNOS regulation, has not been determined. We generated cells with manipulated PI3K signaling by expressing the activating mutation, PIK3CAH1047R, or knocking down PTEN expression. We investigated eNOSS1177 phosphorylation, a major activating regulatory site, following mTORC1 inhibition. We also tested the sufficiency of mTORc1 activation to stimulate eNOSS1177 phosphorylation. Our data indicate mTORc1 activity is required for the phosphorylation of eNOSS1177, even in the presence of robust AKT activation. Moreover, we found that expression of RHEB, which functions in the absence of AKT activation to activate mTORc1, is sufficient to phosphorylate this site. Our data indicate that mTORc1, rather than AKT, may be the critical determinant of eNOSS1177 phosphorylation. As mTORc1 is a central regulator of cellular metabolism, the finding that this regulatory complex can directly participate in the regulation of eNOS provides new insights into metabolic uncoupling and vascular disease that often accompanies diabetes, high fat diets, and aging.Keywords
Funding Information
- DOD Neurofibromatosis Program (W81XWH-13-1-0111)
- David E. Bryant Trust
- Leopold Fund for Vascular Anomalies
This publication has 48 references indexed in Scilit:
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling SymphonyJournal of Biological Chemistry, 2010
- Activation of Endothelial Ras Signaling Bypasses Senescence and Causes Abnormal Vascular MorphogenesisCancer Research, 2010
- Tsc2-Rheb signaling regulates EphA-mediated axon guidanceNature Neuroscience, 2010
- eNOS, metabolic syndrome and cardiovascular diseaseTrends in Endocrinology & Metabolism, 2009
- VEGF‐Mediated Elevated Intracellular Calcium and Angiogenesis in Human Microvascular Endothelial Cells In Vitro are Inhibited by Dominant Negative TRPC6Microcirculation, 2008
- Characterization of the Rheb‐mTOR Signaling Pathway in Mammalian Cells: Constitutive Active Mutants of Rheb and mTOR2008
- The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and managementJournal of Medical Genetics, 2007
- Mutation of the PIK3CA oncogene in human cancersBritish Journal of Cancer, 2006